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Objectives
Analyze the number and indication for insertion of cen-
tral venous catheters (CVCs), the incidence of catheter-
related bloodstream infection (CRBSI) and the mortality
in the intensive care unit (ICU), and after discharge to
ward, in patients requiring CVCs in the ICU.
Methods
Retrospective, descriptive analysis, from October 2013 to
December 2014, of all patients admitted to the ICU. We
considered: age, gender, Apache II, indication for canaliza-
tion of CVC, number of CVCs, days in ICU with CVC,
CRBSI and mortality in ICU and after discharge to ward, if
at the time of discharge patients were carrying CVC.
Results
590 admitted patients: age 64.4 ± 15.4 years, 65% males,
Apache II14.6 ± 9.2. 54.4% (321/590) required CVC.
Apache II - with CVC 19.2 ± 9.4 vs 9.1 ± 5 without
CVC (p < 0.001). One CVC was inserted in 231 (72%), 2
in 72 (22.4%), 3 in 14 (4.4%), 4 in 2 (0.6%) and 5 in
another 2 (0.6%). A total of 435 CVCs were inserted:
40% subclavian, 31.7% jugular, 26.9% femoral and 1.4%
peripherally inserted central catheters.The main reason
for CVCs was: sedation 68.8% (221), catecholamines
65.1% (209), either 83% (266) or both 51.1% (164); other
causes: insulin infusion 15.9% (51), parenteral feeding
12.8% (41), continuous renal replacement therapy 7.5%
(24), other 6.5% (21).The total CVC days in the ICU
was 2545; 1 CRBSI episode was diagnosed (CRBSI
incidence density 0.4 episodes/1000 catheter days). The
total number of days of stay in the ICU was 2805.95
days (incidence density 0.36 episodes/1000 income
days). CVC utilization ratio: 0.91.For patients requiring
CVC, 43% (116/270) were discharged to ward with
CVC. In ward, CRBSI incidence density was 0.29 epi-
sodes/1000 catheter days in hospital after ICU (one
patient in 3476 days). We could not specify the number
of days with CVC after discharge from ICU.
Mortality analysis showed:
1) In ICU: patients with CVC 15.9% (51/321) vs with-
out CVC 1.5% (4/269), p < 0.001; OR 12.5 (95% CI 4.5-
35.1); (Apache II 28.3 ± 9.5 vs 20.5 ± 18.4, p = 0.148
NS).
2) After discharge from ICU: patients with CVC 8.6%
(10/116) vs without CVC 2.6% (11/419); p = 0.003 (OR
3.5, 95% CI 1.4-8.5); Apache II 16.87 ± 84 vs 12.23 ± 7.5
(p < 0.001).
Conclusions
In our study, more than half of the patients admitted to
the ICU pointed CVCs.
72% needed only one CVC, subclavian or jugular
(71.7%), mainly for using catecholamines or sedatives. In
the ICU, CRBSI incidence density was 0.4/1000 catheter
days. This rate could not be clarified after discharge to
ward. The mortality in ICU and after discharge to ward
was higher in more seriously ill patients and those with
CVC, although none died of CRBSI.
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